(PB) >>20902207
>Vaccine-Induced Myocarditis
Which one? 😎
Vaccine History: Developments by Year
https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-history/developments-by-year
The 1970s — vaccine success
During the 1970s, one vaccine was eliminated. Because of successful eradication efforts, the smallpox vaccine was no longer recommended for use after 1972. While vaccine research continued, new vaccines were not introduced during the 1970s.
Late 1970s | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Polio (OPV)
Measles**
Mumps**
Rubella**
-
Given in combination as DTP
** Given in combination as MMR
Vaccine development in the 1980s — hepatitis B and Haemophilus influenzae type b
The vaccine for Haemophilus influenzae type b was licensed in 1985 and placed on the recommended schedule in 1989. When the schedule was published again in 1994, the hepatitis B vaccine had been added.
The hepatitis B vaccine was not new, as it had been licensed in 1981 and recommended for high-risk groups such as infants whose mothers were hepatitis B surface antigen positive, healthcare workers, intravenous drug users, homosexual men and people with multiple sexual partners. However, immunization of these groups didn't effectively stop transmission of hepatitis B virus. That’s because about one-third of patients with acute disease were not in identifiable risk groups. The change of recommendation to immunize all infants in 1991 was the result of these failed attempts to control hepatitis B by only immunizing high-risk groups. Following this recommendation, hepatitis B disease was virtually eliminated in children less than 18 years of age in the United States.
1985 - 1994 | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Measles**
Mumps**
Rubella**
Polio (OPV)
Hib
1994 - 1995 | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Measles**
Mumps**
Rubella**
Polio (OPV)
Hib
Hepatitis B
-
Given in combination as DTP
** Given in combination as MMR
Annual updates to the immunization schedule — 1995 to 2010
As more vaccines became available, an annual update to the schedule was important because of changes that providers needed to know, such as detailed information about who should receive each vaccine, age(s) of receipt, number of doses, time between doses, or use of combination vaccines. New vaccines were also added.
Important changes to the schedule between 1995 and 2010 included:
New vaccines: Varicella (chickenpox - 1996), rotavirus (1998-1999; 2006, 2008); hepatitis A (2000); pneumococcal vaccine (2001)
Additional recommendations for existing vaccines: influenza (2002); hepatitis A (2006)
New versions of existing vaccines: acellular pertussis vaccine (DTaP ,1997); intranasal influenza (2004)
Discontinuation of vaccine: Oral polio vaccine (2000)
2000 | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Measles**
Mumps**
Rubella**
Polio (IPV)
Hib
Hepatitis B
Varicella
Hepatitis A
2005 | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Measles**
Mumps**
Rubella**
Polio (IPV)
Hib
Hepatitis B
Varicella
Hepatitis A
Pneumococcal
Influenza
2010 | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Measles**
Mumps**
Rubella**
Polio (IPV)
Hib
Hepatitis B
Varicella
Hepatitis A
Pneumococcal
Influenza
Rotavirus
-
Given in combination as DTaP
** Given in combination as MMR
The schedule from 2011 to Present
Annual updates to both the childhood and adult immunization schedules offer guidance to healthcare providers in the form of new recommendations, changes to existing recommendations, or clarifications to assist with interpretation of the schedule in certain circumstances. The schedules are reviewed by committees of experts from the Centers for Disease Control and Prevention, the American Academy of Pediatrics, and the American Academy of Family Physicians.
Important changes to the schedule:
New vaccines: meningococcal serogroup B vaccine (2014); COVID-19 (2021-2022)†
Additional recommendations for existing vaccines: HPV (2011 to routinely vaccinate males), intranasal influenza vaccine (2018 again recommended)
Discontinuation of vaccine: intranasal influenza vaccine (2016)
†COVID-19 vaccines were recommended during the pandemic for increasingly younger age groups starting in late 2020. They were recommended for 5- to 11-year-olds in 2021, but they were not recommended for those younger than 5 years of age until 2022. COVID-19 vaccine was not added to the immunization schedule until 2023.
2020 | Recommended Vaccines
Diphtheria*
Tetanus*
Pertussis*
Measles**
Mumps**
Rubella**
Polio (IPV)
Hib
Hepatitis B
Varicella
Hepatitis A
Pneumococcal
Influenza
Rotavirus
-
Given in combination as DTaP
** Given in combination as MMR